...
【24h】

Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia.

机译:与良性前列腺增生相比,Nedd4L表达在前列腺癌中下调。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIMS: To characterize aspects of Nedd4L in prostate cancer (PC) by assessing its expression in hyperplastic and malignant prostate tissue, and to correlate findings with PC histologic grade. MATERIALS AND METHODS: Radical prostatectomy (RP) specimens from 56 patients with clinically localized PC, and benign prostatic hyperplasia (BPH) transurethral resection specimens from 31 patients, were assessed for Nedd4L expression using immunohistochemistry. RESULTS: Nedd4L (P<0.001) expressions were significantly decreased in PC compared to benign prostate tissue. Furthermore, downregulation of Nedd4L (P<0.05) expression correlated with increasing Gleason score. CONCLUSIONS: These data suggest that prostate cancer cells in vivo may need Nedd4L expression to regulate TGF-beta1 signaling, and that Nedd4L expression might be involved in prostate cancer development.
机译:目的:通过评估Nedd4L在增生性和恶性前列腺组织中的表达来表征Nedd4L在前列腺癌(PC)中的各个方面,并将发现与PC组织学分级相关联。材料与方法:采用免疫组织化学方法评估了56例临床局限性PC的根治性前列腺切除术(RP)标本和31例患者的良性前列腺增生(BPH)经尿道切除术标本的Nedd4L表达。结果:与良性前列腺组织相比,PC中Nedd4L(P <0.001)的表达显着降低。此外,Nedd4L表达的下调(P <0.05)与格里森评分的升高相关。结论:这些数据表明体内前列腺癌细胞可能需要Nedd4L表达来调节TGF-beta1信号传导,并且Nedd4L表达可能与前列腺癌的发展有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号